Literature DB >> 20954814

Blood aging, safety, and transfusion: capturing the "radical" menace.

Paul W Buehler1, Elena Karnaukhova, Monique P Gelderman, Abdu I Alayash.   

Abstract

Throughout their life span, circulating red blood cells (RBCs) transport oxygen (O(2)) primarily from the lungs to tissues and return with carbon dioxide (CO(2)) from respiring tissues for final elimination by lungs. This simplistic view of RBCs as O(2) transporter has changed in recent years as other gases, for example, nitric oxide (NO), and small molecules, such as adenosine triphosphate (ATP), have been shown to either be produced and/or carried by RBCs to perform other signaling and O(2) sensing functions. In spite of the numerous biochemical and metabolic changes occurring within RBCs during storage, prior to, and after transfusion, perturbations of RBC membrane are likely to affect blood flow in the microcirculation. Subsequent hemolysis due to storage conditions and/or hemolytic disorders may have some pathophysiological consequences as a result of the release of Hb. In this review, we show that evolution has provided a multitude of protection and intervention strategies against free Hb from "cradle" to "death"; from early biosynthesis to its final degradation and a lot more in between. Furthermore, some of the same naturally occurring protective mechanisms can potentially be employed to oxidatively inactivate this redox active protein and control its damaging side reactions when released outside of the RBC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20954814     DOI: 10.1089/ars.2010.3447

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  22 in total

Review 1.  Nitric oxide formation versus scavenging: the red blood cell balancing act.

Authors:  Benjamin Y Owusu; Ryan Stapley; Rakesh P Patel
Journal:  J Physiol       Date:  2012-06-11       Impact factor: 5.182

Review 2.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

3.  Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock.

Authors:  Chong Lei; Binglan Yu; Mohd Shahid; Arkadi Beloiartsev; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2012-12       Impact factor: 7.892

Review 4.  Molecular controls of the oxygenation and redox reactions of hemoglobin.

Authors:  Celia Bonaventura; Robert Henkens; Abdu I Alayash; Sambuddha Banerjee; Alvin L Crumbliss
Journal:  Antioxid Redox Signal       Date:  2013-01-21       Impact factor: 8.401

Review 5.  Blood substitutes: why haven't we been more successful?

Authors:  Abdu I Alayash
Journal:  Trends Biotechnol       Date:  2014-03-12       Impact factor: 19.536

Review 6.  Development of recombinant hemoglobin-based oxygen carriers.

Authors:  Cornelius L Varnado; Todd L Mollan; Ivan Birukou; Bryan J Z Smith; Douglas P Henderson; John S Olson
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

7.  Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.

Authors:  Steven B Solomon; Landon Bellavia; Daniel Sweeney; Barbora Piknova; Andreas Perlegas; Christine C Helms; Gabriela A Ferreyra; S Bruce King; Nicolaas J H Raat; Steven J Kern; Junfeng Sun; Linda C McPhail; Alan N Schechter; Charles Natanson; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Free Radic Biol Med       Date:  2012-10-23       Impact factor: 7.376

8.  In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.

Authors:  Dong Wang; Barbora Piknova; Steven B Solomon; Irene Cortes-Puch; Steven J Kern; Junfeng Sun; Tamir Kanias; Mark T Gladwin; Christine Helms; Daniel B Kim-Shapiro; Alan N Schechter; Charles Natanson
Journal:  Transfusion       Date:  2013-03-14       Impact factor: 3.157

9.  Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.

Authors:  Andres S Benitez Cardenas; Premila P Samuel; John S Olson
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

Review 10.  βCysteine 93 in human hemoglobin: a gateway to oxidative stability in health and disease.

Authors:  Abdu I Alayash
Journal:  Lab Invest       Date:  2020-09-26       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.